Probiotic Therapy Fails to Improve Gut Permeability in a Hapten Model of Colitis

References

• Sartor RB. Microbial factors in the pathogenesis of Crohn’s disease, ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. 4th ed. Baltimore (MD): Williams & Wilkins; 1995. p. 96–124.
   Google Scholar
• Sartor RB. Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis [Review article]. Aliment Pharmacol Ther 1997;11 Suppl 3:17–23.
   PubMed Web of Science ®Google Scholar
• Harper PH, Truelove SC, Lee ECG, Kettlewell MGW, Jewell DP. Split ileostomy and ileocolostomy for Crohn’s disease of the colon and ulcerative colitis: a twenty year survey. Gut 1983;23:106–13.
   Google Scholar
• D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262–7.
   Google Scholar
• Sundberg JP, Elson CO, Bedigian H, Birkenmeier EH. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 1994;107:1726–35.
   PubMed Web of Science ®Google Scholar
• Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhoum M, Fernandez-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease of HLA-B27 transgenic rats. J Exp Med 1994;180: 2359–64.
   Google Scholar
• Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253–61.
   PubMed Web of Science ®Google Scholar
• Kuhn R, Löhler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263–74.
   PubMed Web of Science ®Google Scholar
• Seneca H, Henderson E. Normal intestinal bacteria in ulcerative colitis. Gastroenterology 1950;15:34–9.
   PubMed Web of Science ®Google Scholar
• Keighley MRB, Arabi Y, Dimock F, Burdon DW, Allan RN. Influence of inflammatory bowel disease on the intestinal microflora. Gut 1978;19:1099–104.
   Google Scholar
• Dickinson RJ, Varian SA, Axon ATR, Cooke EM. Increased incidence of faecal coliforms with in-vitro adhesive and invasive properties in patients with ulcerative colitis. Gut 1980;21:787–92.
   PubMed Web of Science ®Google Scholar
• Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 1991;35: 238–43.
   Google Scholar
• Ambrose NS, Young D, Burdon DW, Keighley MRB. Changes in intestinal flora in Crohn’s disease. Br J Surg 1982;69:681.
   Web of Science ®Google Scholar
• Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal α-D-galactosidase production and bifidobacteria are decreased in Crohn’s disease. Dig Dis Sci 1997;42:817–22.
   PubMed Web of Science ®Google Scholar
• Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human lactobacillus strain. Antimicrob Agents Chemother 1987;31:1231–3.
   PubMed Web of Science ®Google Scholar
• Fernandes CF, Shahami KM, Amer MA. Therapeutic role of dietary lactobacilli and lactobacilli fermented dairy products. FEMS Microbiol Rev 1987;46:343–56.
   Google Scholar
• Salminen S, Deighton M, Gorbach SL. Lactic acid bacteria in health and disease. In: Salminen S, von Wright A, editors. Lactic acid bacteria. New York: Dekker; 1993. p. 531–7.
   Google Scholar
• Fuller R, editor. Probiotics: the scientific basis. London: Chapman & Hall; 1992.
   Google Scholar
• van der Waiij D. Colonisation resistance of the digestive tract-mechanisms and clinical consequences. Nahrung 1987;31:507–17.
   PubMedGoogle Scholar
• Ryan CM, Schmidt J, Lewandrowski K, Compton CC, Rattner DW, Warshaw AL, et al. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats. Gastroenterology 1993;104:890–5.
   PubMed Web of Science ®Google Scholar
• Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989; 96:29–36.
   PubMed Web of Science ®Google Scholar
• Neilly PJ, Gardiner KR, Jennings C, Anderson NH, Elia M, Rowlands BJ. Endotoxaemia and cytokine production in experimental colitis. Br J Surg 1995;82:1479–82.
   PubMed Web of Science ®Google Scholar
• Morris GP, Beck PL, Herridge MS, et al. Hapten induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795–803.
   PubMed Web of Science ®Google Scholar
• Gardiner KR, Erwin PJ, Anderson NH, Barr JG, Halliday MI, Rowlands BJ. Colonic bacteria and bacterial translocation in experimental colitis. Br J Surg 1993;80:512–6.
   PubMed Web of Science ®Google Scholar
• Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66:365–78.
   PubMedGoogle Scholar
• Metha AM, Patel KA, Dave PJ. Isolation and purification of an inhibitory protein from Lactobacillus acidophilus AC1. Microbios 1983;37: 37–43.
   Google Scholar
• Atrih A, Rekhif N, Michel M, Lefebvre G. Detection of bacteriocins produced by Lactobacillus plantarum strains isolated from different foods. Microbios 1993;75:117–23.
   PubMedGoogle Scholar
• Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hadault S. The human Lactobacillus acidophilus strain LA1 secretes a non bacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 1997;63: 2747–53.
   Google Scholar
• Jónsson S, Clausen E, Raa J. Amino acid degradation by a Lactobacillus plantarum strain from fish. Syst Appl Microbiol 1983;4: 148–54.
   PubMed Web of Science ®Google Scholar
• Wright CE, Rees DD, Moncada S. Protective and pathological role of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48–57.
   Google Scholar
• Duncan C, Dougall H, Johnston P, Green S, Brogan R, Leifert C, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1995;1: 546–51.
   PubMed Web of Science ®Google Scholar
• Coconnier MH, Bernet MF, Kerneis S, Chauviere G, Fourniat J, Alain SL. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by L. acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett 1993;110: 299–306.
   PubMed Web of Science ®Google Scholar
• Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994;35: 483–9.
   Google Scholar
• Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994;Suppl 1:S35–8.
   Google Scholar
• Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992;103: 51–6.
   PubMed Web of Science ®Google Scholar
• Steinhart AH, Brzezinski A, Baker JP. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 1994;89:179–83.
   Google Scholar
• Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immune modulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491–7.
   Google Scholar
• Perdigon G, Alvarez S, Rachid M, Agüero G, Gobatto N. Immune system stimulation by probiotics. J Dairy Sci 1995;78: 1597–1606.
   PubMed Web of Science ®Google Scholar
• Fabia R, Ar’rajab A, Johansson ML, Andersson R, Willen R, Jeppsson B, et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993;54:248–55.
   PubMed Web of Science ®Google Scholar
• Caldrini de Bustos MI, Schiffrin EJ, Ogawa de Furuya K, Caccamo DV, Ledesma de Paolo MI, Celener D, et al. Prevention of carrageenan-induced ulcerative colitis in the guinea pig by serum of bovine colostrum. Medicina 1987;47: 273–7.
   PubMed Web of Science ®Google Scholar
• Fabia R, Ar’rajab A, Johannson ML, Willen R, Andersson R. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol 1993;28:155–62.
   PubMed Web of Science ®Google Scholar
• Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology 1999;116: 1107–14.
   Google Scholar
• Schultz M, Veltkamp C, Dieleman LA, Wyrick PB, Tonkonogy SL, Sartor RB. Continuous feeding of Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient mice. Gastroenterology 1998;114:A1081.
   Web of Science ®Google Scholar
• Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn’s disease by oral bacteriotherapy with lactobacillus GG. Ann Nutr Metab 1996; 40:137–45.
   PubMed Web of Science ®Google Scholar
• Malchow HA. Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease. J Clin Gastroenterol 1997;25:653–8.
   Google Scholar
• Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997;11:853–8.
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A, Matteuzzi D, Rossi M, Peruzzo S, et al. Maintenance treatment of chronic pouchitis: a randomised placebo-controlled trial with a new probiotic preparation. Gastroenterology 1998;114:A985.
   Web of Science ®Google Scholar
• Venturi A, Gionchetti P, Rizzello F, Brigidi P, Rossi M, Johanson R, et al. Colonisation of patients with ulcerative colitis in remission by a new probiotic preparation. Gastroenterology 1998;114:A1109.
   Web of Science ®Google Scholar